Bristol-Myers Squibb's Opdivo misses its shot at earlier use in liver cancer - FiercePharma
- Bristol-Myers Squibb's Opdivo misses its shot at earlier use in liver cancer FiercePharma
- Bristol-Myers Squibb, Celgene slide following news of delayed deal and psoriasis drug divestment CNBC
- Bristol-Myers Squibb Stock Is Falling as Celgene Deal Faces Setback Barron's
- Bristol-Myers Will Divest Celgene Blockbuster to Close Deal Yahoo Finance
- Bristol-Myers’ Celgene Deal Can Still Be a Winner The Wall Street Journal
- View full coverage on Google News